Three main paths (GE1, GE2 and GE3) have been identified. GE1: Cloning and restriction endonuclease (REs); GE2: core genome editing; GE3: Endonuclease and related enzymes. Labeled nodes represent patents and are identified in the side table with the patent number which allows one to search for and read the patent on various databases.</p
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
The patents in GE2 are identified in clusters of different technologies shown in the table in the up...
Eight key patents in the main path and core of genome editing which are also in the CRISPR roots set...
Three main paths (CR1, CR2, and CR3) have been identified. CR1: Technologies for introducing nucleic...
This paper applies objective methods to explore the technological origins of the widely acclaimed CR...
119-127The paper discusses the patenting on genes as well as potential patents on gene fragments of ...
(A) patents granted yearly 1999–2017; (B) Top 10 assignees (with formal names) New England Biolabs, ...
© 1996 Helen RofeAscertaining the sequence of the human genome has long been the 'holy grail' of the...
Thesis (Ph.D.)--University of Washington, 2013LAGLIDADG Homing Endonucleases (LHEs) are a family of ...
The various research efforts that comprise the Human Genome Project will inevitably both draw on and...
In November 2000, the Genetic Services Committee of the National Society of Genetic Counselors (NSGC...
A new study has mapped human genes to patents and finds just how many are involved in commercial int...
A goal of synthetic biology bio-foundries is to innovate through an iterative design/build/test/lear...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
The patents in GE2 are identified in clusters of different technologies shown in the table in the up...
Eight key patents in the main path and core of genome editing which are also in the CRISPR roots set...
Three main paths (CR1, CR2, and CR3) have been identified. CR1: Technologies for introducing nucleic...
This paper applies objective methods to explore the technological origins of the widely acclaimed CR...
119-127The paper discusses the patenting on genes as well as potential patents on gene fragments of ...
(A) patents granted yearly 1999–2017; (B) Top 10 assignees (with formal names) New England Biolabs, ...
© 1996 Helen RofeAscertaining the sequence of the human genome has long been the 'holy grail' of the...
Thesis (Ph.D.)--University of Washington, 2013LAGLIDADG Homing Endonucleases (LHEs) are a family of ...
The various research efforts that comprise the Human Genome Project will inevitably both draw on and...
In November 2000, the Genetic Services Committee of the National Society of Genetic Counselors (NSGC...
A new study has mapped human genes to patents and finds just how many are involved in commercial int...
A goal of synthetic biology bio-foundries is to innovate through an iterative design/build/test/lear...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...
As public and private sector initiatives race to complete the sequence of the human genome, patent i...